Anas Belouali

Johns Hopkins University — United States

Medicine · Health Sciences

11h-index855citations75works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory mediators and NSAID effects(25), Cancer, Stress, Anesthesia, and Immune Response(24), Cancer, Lipids, and Metabolism(20), Cancer Immunotherapy and Biomarkers(10), Suicide and Self-Harm Studies(7)

Publications66 total

Navigating extreme class imbalance in suicide risk prediction
Frontiers in Psychiatry·2026Open Access
Considerations for evaluating the practical utility of machine learning in suicide risk estimation: the role of cost and equity
2025Open Access
Use of Vital Records to Improve Identification of Suicide as Manner of Death for Opioid-Related Fatalities
Crisis·2025· 1 citedOpen Access
Identifying and characterizing suicide decedent subtypes using deep embedded clustering
Scientific Reports·2025· 1 citedOpen Access
Determining the feasibility and acceptability of a randomized telehealth pilot study for veterans with chronic multisymptom illness
Pilot and Feasibility Studies·2025· 1 citedOpen Access
Correction: Assessing the Racial and Socioeconomic Disparities in Postpartum Depression Using Population-Level Hospital Discharge Data: Longitudinal Retrospective Study
JMIR Pediatrics and Parenting·2024Open Access
Correction: Assessing the Racial and Socioeconomic Disparities in Postpartum Depression Using Population-Level Hospital Discharge Data: Longitudinal Retrospective Study (Preprint)
2024
Suicide Death Prediction Using the Maryland Suicide Data Warehouse: A Sensitivity Analysis
Archives of Suicide Research·2024· 3 cited
Evaluation of crowdsourced mortality prediction models as a framework for assessing artificial intelligence in medicine
Journal of the American Medical Informatics Association·2023· 8 citedOpen Access
Gulf War Illness: A Randomized Controlled Trial Combining Mindfulness Meditation and Auricular Acupuncture
Global Advances in Integrative Medicine and Health·2023· 5 citedOpen Access
Supplementary Table S5 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
2023Open Access
Supplementary Figure S4 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
2023Open Access
Supplementary Figure S2 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
2023Open Access
Supplementary Figure S1 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
2023Open Access
Supplementary Table S1 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
2023Open Access
Supplementary Table S2 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
2023Open Access
Supplementary Table S3 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
2023Open Access
Data from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
2023Open Access
Supplementary Table S6 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
2023Open Access
Supplementary Table S2 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Subha Madhavan(34), Samir Gupta(20), Michael B. Atkins(13), Jason Roszik(13), J. Jack Lee(13), Yu‐Hung Wu(13), Masanori Kawakami(13), Jonathan M. Kurie(13), Simina M. Boca(13), Robert A. Beckman(13), Ethan Dmitrovsky(13), Neil J. Shah(12), Adil Alaoui(10), Michael Serzan(9), Matthew Blackburn(8), Hadi Kharrazi(7), Xi Liu(7), Michael Cook(5), Stephen V. Liu(5), Geoffrey T. Gibney(5)